| Literature DB >> 25992535 |
Sonia M D Brucki1, Norberto Anísio Frota1, Pedro Schestatsky1, Adélia Henriques Souza1, Valentina Nicole Carvalho1, Maria Luiza Giraldes Manreza1, Maria Fernanda Mendes1, Elizabeth Comini-Frota1, Cláudia Vasconcelos1, Vitor Tumas1, Henrique B Ferraz1, Egberto Barbosa1, Mauro Eduardo Jurno1.
Abstract
The use of cannabidiol in some neurological conditions was allowed by Conselho Regional de Medicina de São Paulo and by Agência Nacional de Vigilância Sanitária (ANVISA). Specialists on behalf of Academia Brasileira de Neurologia prepared a critical statement about use of cannabidiol and other cannabis derivatives in neurological diseases.Entities:
Mesh：
Substances：
Year: 2015 PMID： 25992535 DOI： 10.1590/0004-282X20150041
Source DB: PubMed Journal: Arq Neuropsiquiatr ISSN： 0004-282X Impact factor: 1.420